SCHEMBL7740284

SCHEMBL7740284

NC(=O)c1c[nH]c2ccc(N3CCOCC3)cc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 4/20 0.49
HSD17B10 Q99714 3/20 0.49
JAK1 P23458 2/20 0.49
TYK2 P29597 2/20 0.49
JAK3 P52333 2/20 0.49
KDM4E B2RXH2 5/20 0.47
HPGD P15428 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
PTPN7 P35236 1/20 0.47
KIF11 P52732 3/20 0.47
GAA P10253 2/20 0.47
MAP2 P11137 1/20 0.46
ALDH1A1 P00352 6/20 0.45
GLA P06280 1/20 0.45
TSHR P16473 1/20 0.45
TBK1 Q9UHD2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3093023 0.91 JAK2 (0.52) JAK2JAK1TYK2JAK3KDM4E
SCHEMBL9051473 0.80 HPGD (0.52) JAK2HSD17B10JAK1TYK2JAK3
SCHEMBL7738734 0.79 ALDH1A1 (0.72) HSD17B10KDM4EHPGDKMT2AMAPT
SCHEMBL15281971 0.79 GAA (0.48) JAK2HSD17B10KDM4EHPGDKMT2A
SCHEMBL27743061 0.78 FGFR1 (0.46) HSD17B10KDM4EHPGDKMT2AMAPT
SCHEMBL9596257 0.77 HSD17B10 (0.59) HSD17B10KDM4EHPGDKMT2AMAPT
SCHEMBL6205521 0.77 ALDH1A1 (0.67) HSD17B10KDM4EHPGDKMT2AMAPT
SCHEMBL4351617 0.74 PRKDC (0.59) JAK2HSD17B10JAK1TYK2JAK3
SCHEMBL30689022 0.73 ALDH1A1 (0.62) HSD17B10JAK1JAK3KDM4EHPGD
SCHEMBL20935019 0.72 HPGD (0.56) HSD17B10KDM4EHPGDKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US disclosed